share_log

Philip (Phil) Powell Buys 19,481 Shares of INOVIQ Ltd (ASX:IIQ) Stock

Philip (Phil) Powell Buys 19,481 Shares of INOVIQ Ltd (ASX:IIQ) Stock

菲利普(菲爾)鮑威爾買入 INOVIQ 有限公司 19,481 股股票
Financial News Live ·  2023/03/09 09:40

INOVIQ Ltd (ASX:IIQ – Get Rating) insider Philip (Phil) Powell acquired 19,481 shares of INOVIQ stock in a transaction dated Friday, March 3rd. The stock was bought at an average price of A$0.56 ($0.38) per share, for a total transaction of A$10,909.36 ($7,321.72).

INOVIQ 有限公司(ASX:IIQ-獲得評級)內幕菲利普(菲爾)鮑威爾在 3 月 3 日(星期五)的交易中收購了 19,481 股 INNOVIQ 股票。該股票以每股 0.56 澳元(0.38 美元)的平均價格買入,交易總額為 10,909.36 澳元(7,321.72 美元)。

Philip (Phil) Powell also recently made the following trade(s):

菲利普(Phil)鮑威爾最近還進行了以下交易:

Get
取得
INOVIQ
INOVIQ
alerts:
警報:
  • On Monday, March 6th, Philip (Phil) Powell acquired 20,000 shares of INOVIQ stock. The stock was bought at an average price of A$0.57 ($0.38) per share, for a total transaction of A$11,400.00 ($7,651.01).
  • On Wednesday, March 1st, Philip (Phil) Powell acquired 18,518 shares of INOVIQ stock. The stock was bought at an average price of A$0.54 ($0.36) per share, for a total transaction of A$9,999.72 ($6,711.22).
  • 3 月 6 日星期一,菲利普(菲爾)鮑威爾收購了 2 萬股 INOVIQ 股票。該股票以每股 0.57 澳元(0.38 美元)的平均價格買入,交易總額為 11,400.00 澳元(7,651.01 美元)。
  • 3 月 1 日星期三,菲利普(菲爾)鮑威爾收購了 18,518 股 INOVIQ 股票。該股票以每股 0.54 澳元(0.36 美元)的平均價格買入,交易總額為 9,999.72 澳元(6,711.22 美元)。

INOVIQ Price Performance

價格表現

The company has a debt-to-equity ratio of 3.73, a current ratio of 5.28 and a quick ratio of 9.52.

該公司的債務與權益比率為 3.73,流動比率為 5.28,快速比率為 9.52。

INOVIQ Company Profile

盈盈科技公司簡介

(Get Rating)

(取得評分)

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample.

INOVIQ Ltd 從事診斷和外出體產品的研究,開發和商業化,以加強澳大利亞和美國癌症和其他疾病的診斷和治療。該公司提供 hTert test,這是一種免疫細胞化學 test,用作膀胱癌尿細胞學測試的輔助性測試;EXO-NET 用於從液體活檢樣本中捕獲和隔離外泌體。

Further Reading

進一步閱讀

  • REV Group Hits A Wall Despite Results And Outlook
  • Oil Tankers In Buy Range After Breaking Out Of Bases
  • United Natural Foods Under Delivered...Did the Market Overreact?
  • Can Cricut Stock Jump Higher In 2023?
  • 10 Best Consumer Staples ETFs
  • REV 集團觸及牆儘管業績和前景
  • 油輪在買入範圍內突破基地後
  • 美國天然食品交付... 市場反應過度嗎?
  • 土豆股票可以在 2023 年跳得更高嗎?
  • 10 大最佳消費者指數 ETF

Receive News & Ratings for INOVIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INOVIQ and related companies with MarketBeat.com's FREE daily email newsletter.

接收 INOVIQ 每日最新消息和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 INOVIQ 和相關公司的最新新聞和分析師評級的簡要每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論